Last $179.67 USD
Change Today +1.48 / 0.83%
Volume 3.0M
AGN On Other Exchanges
Symbol
Exchange
New York
Berlin
As of 8:04 PM 10/1/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Scott M. Whitcup M.D.

Chief Scientific Officer and Executive Vice President of Research & Development, Allergan Inc.
AgeTotal Calculated CompensationThis person is connected to 54 board members in 3 different organizations across 4 different industries.

See Board Relationships
55$2,913,089
As of Fiscal Year 2013

Background*

Dr. Scott M. Whitcup, M.D. has been the Chief Scientific Officer of Allergan Inc. since April 2009 and has also been its Executive Vice President of Research and Development since July 28, 2004. Dr. Whitcup is responsible for Allergan's drug discovery efforts as well as the ophthalmology, Botox(R)/neurology, skin care and new technology development programs worldwide. He joined Allergan in January 2000 as Vice President of Development and Ophthalmology. He served as ...

Read Full Background

Corporate Headquarters*

2525 Dupont Drive
Irvine, California 92612

United States

Phone: 714-246-4500
Fax: 714-246-6987

Board Members Memberships*

Director
Director
2005-2014
Former Director, Chairman of Science Committee, Member of Executive Committee and Member of Corporate Governance Committee
2012-Present
Director, Chairman of Compliance Committee and Chairman of Science Committee

Education*

Bachelor's Degree
Cornell University
MD
Weill Cornell Medical College, New York

Other Affiliations*

Annual Compensation*

Salary$642,115
Total Annual Compensation$642,115

Stock Options*

All Other Compensation$39,529
Exercised Options107,800
Exercised Options Value$7,619,130
Exercisable Options579,500
Exercisable Options Value$31,419,570
Unexercisable Options218,400
Unexercisable Options Value$5,388,785
Total Value of Options$44,427,485
Total Number of Options905,700

Total Compensation*

Total Annual Cash Compensation$1,158,144
Total Short Term Compensation$642,115
Other Long Term Compensation$39,529
Total Calculated Compensation$2,913,089
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
AGN:US $179.67 USD +1.48

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Leonard S. Schleifer M.D., Ph.D.Co-Founder, Chief Executive Officer, President, Executive Director and Ex Officio Member of Technology Committee
Regeneron Pharmaceuticals, Inc.
$3.1M
Brenton L. Saunders J.D.Chief Executive Officer, President and Director
Actavis plc
--
Dilip Shantilal Shanghvi Managing Director, Executive Director and Member of Shareholders/Investors Grievance Committee
Sun Pharmaceutical Industries Limited
23.1M
Flemming Ornskov M.D., MBA, MPHChief Executive Officer, Managing Director and Director
Shire plc
$2.7M
Yoshihiko Hatanaka Chief Executive Officer, President and Representative Director
Astellas Pharma, Inc.
--
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ALLERGAN INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.